AGT and atrial fibrillation: In the combination therapy of RFA and spironolactone, spironolactone can directly antagonize the effects of ALD and AngII, reverse the electrical and structural remodeling of the atrium caused by the above two factors, reduce the diameter of the left atrium and the occurrence of AF, and improve the left ventricular function in patients with AF.